Literature DB >> 32152097

Intestinal bile acids directly modulate the structure and function of C. difficile TcdB toxin.

John Tam1, Simoun Icho1,2, Evelyn Utama1,2, Kathleen E Orrell2, Rodolfo F Gómez-Biagi1,3, Casey M Theriot4, Heather K Kroh5, Stacey A Rutherford5, D Borden Lacy5, Roman A Melnyk6,2,3.   

Abstract

Intestinal bile acids are known to modulate the germination and growth of Clostridioides difficile Here we describe a role for intestinal bile acids in directly binding and neutralizing TcdB toxin, the primary determinant of C. difficile disease. We show that individual primary and secondary bile acids reversibly bind and inhibit TcdB to varying degrees through a mechanism that requires the combined oligopeptide repeats region to which no function has previously been ascribed. We find that bile acids induce TcdB into a compact "balled up" conformation that is no longer able to bind cell surface receptors. Lastly, through a high-throughput screen designed to identify bile acid mimetics we uncovered nonsteroidal small molecule scaffolds that bind and inhibit TcdB through a bile acid-like mechanism. In addition to suggesting a role for bile acids in C. difficile pathogenesis, these findings provide a framework for development of a mechanistic class of C. difficile antitoxins.

Entities:  

Keywords:  C. difficile; bile acid; pathogenesis; structure; toxin

Mesh:

Substances:

Year:  2020        PMID: 32152097      PMCID: PMC7104382          DOI: 10.1073/pnas.1916965117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Ethaverine in the treatment of angina pectoris.

Authors:  C M VOYLES; H A SIEBER; E S ORGAIN
Journal:  J Am Med Assoc       Date:  1953-09-05

2.  Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases.

Authors:  C von Eichel-Streiber; M Sauerborn; H K Kuramitsu
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

Review 3.  Bile Acid Physiology.

Authors:  Agostino Di Ciaula; Gabriella Garruti; Raquel Lunardi Baccetto; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Ann Hepatol       Date:  2017-11       Impact factor: 2.400

4.  Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.

Authors:  Michelle E LaFrance; Melissa A Farrow; Ramyavardhanee Chandrasekaran; Jinsong Sheng; Donald H Rubin; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

5.  Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.

Authors:  Rajani Thanissery; Jenessa A Winston; Casey M Theriot
Journal:  Anaerobe       Date:  2017-03-06       Impact factor: 3.331

6.  Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants.

Authors:  Pulkit Gupta; Zhifen Zhang; Seiji N Sugiman-Marangos; John Tam; Swetha Raman; Jean-Phillipe Julien; Heather K Kroh; D Borden Lacy; Nicholas Murgolo; Kavitha Bekkari; Alex G Therien; Lorraine D Hernandez; Roman A Melnyk
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

Review 7.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

8.  Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.

Authors:  Johannes Bodenstein; Daniel P Venter; Christiaan B Brink
Journal:  J Pharmacol Exp Ther       Date:  2005-04-27       Impact factor: 4.030

9.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Authors:  Casey M Theriot; Mark J Koenigsknecht; Paul E Carlson; Gabrielle E Hatton; Adam M Nelson; Bo Li; Gary B Huffnagle; Jun Z Li; Vincent B Young
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

10.  Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection.

Authors:  Michael B Francis; Charlotte A Allen; Ritu Shrestha; Joseph A Sorg
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  16 in total

1.  A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection.

Authors:  Tanya M Monaghan; Niharika A Duggal; Elisa Rosati; Ruth Griffin; Jamie Hughes; Brandi Roach; David Y Yang; Christopher Wang; Karen Wong; Lynora Saxinger; Maja Pučić-Baković; Frano Vučković; Filip Klicek; Gordan Lauc; Paddy Tighe; Benjamin H Mullish; Jesus Miguens Blanco; Julie A K McDonald; Julian R Marchesi; Ning Xue; Tania Dottorini; Animesh Acharjee; Andre Franke; Yingrui Li; Gane Ka-Shu Wong; Christos Polytarchou; Tung On Yau; Niki Christodoulou; Maria Hatziapostolou; Minkun Wang; Lindsey A Russell; Dina H Kao
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

2.  Anti-infective bile acids bind and inactivate a Salmonella virulence regulator.

Authors:  Xinglin Yang; Kathryn R Stein; Howard C Hang
Journal:  Nat Chem Biol       Date:  2022-09-29       Impact factor: 16.174

3.  Chemoproteomic Analysis of Microbiota Metabolite-Protein Targets and Mechanisms.

Authors:  Xiaohui Zhao; Xinglin Yang; Howard C Hang
Journal:  Biochemistry       Date:  2022-01-06       Impact factor: 3.321

Review 4.  Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Authors:  Shannon L Kordus; Audrey K Thomas; D Borden Lacy
Journal:  Nat Rev Microbiol       Date:  2021-11-26       Impact factor: 78.297

Review 5.  Capturing the environment of the Clostridioides difficile infection cycle.

Authors:  Matthew K Schnizlein; Vincent B Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

6.  Mechanisms of Colonization Resistance Against Clostridioides difficile.

Authors:  Colleen M Pike; Casey M Theriot
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

Review 7.  Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics.

Authors:  Xiao Tan; Justin H Letendre; James J Collins; Wilson W Wong
Journal:  Cell       Date:  2021-02-10       Impact factor: 41.582

Review 8.  The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection.

Authors:  Benjamin H Mullish; Jessica R Allegretti
Journal:  Therap Adv Gastroenterol       Date:  2021-05-28       Impact factor: 4.409

9.  Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.

Authors:  Sarah Rotondo-Trivette; Beibei Wang; Christopher Gayer; Riddhi Parsana; Yihui Luan; Fengzhu Sun; Sonia Michail
Journal:  Aliment Pharmacol Ther       Date:  2021-07-04       Impact factor: 9.524

Review 10.  Large Clostridial Toxins: Mechanisms and Roles in Disease.

Authors:  Kathleen E Orrell; Roman A Melnyk
Journal:  Microbiol Mol Biol Rev       Date:  2021-06-02       Impact factor: 13.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.